Cryomass Technologies

Cryomass Technologies FCF Yield

The Free Cash Flow Yield of Cryomass Technologies (CRYM) as of Nov 19, 2026 is -1.64 M %. In the previous year, Free Cash Flow Yield was -2.18 M % — a change of -24.92% (higher).

FCF Yield

-1.64 M %

YoY

-24.92%

Last updated:

Free Cash Flow Yield of Cryomass Technologies is 2023 -1.64 M % . Free Cash Flow Yield of Cryomass Technologies was 2022 -2.18 M % . It decreases by -24.92% higher compared to the previous year.

The Cryomass Technologies FCF Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Yield
Date
FCF Yield
Jan 1, 2016
0.00 USD
Jan 1, 2017
-192,624.47 USD
Jan 1, 2018
-400,178.06 USD
Jan 1, 2019
-1.27 M USD
Jan 1, 2020
-2.10 M USD
Jan 1, 2021
-2.88 M USD
Jan 1, 2022
-2.18 M USD
Jan 1, 2023
-1.64 M USD
The Cryomass Technologies FCF Yield history
YEARFCF YieldYoY
-1.64 M %-24.92%
-2.18 M %-24.30%
-2.88 M %+37.21%
-2.10 M %+64.71%
-1.27 M %+218.46%
-400,178.06 %+107.75%
-192,624.47 %—
0.00-100.00%
-63,291.14 %+650.00%
-8,438.82 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cryomass Technologies Stock analysis

What does Cryomass Technologies do? CryoMass Technologies, Inc. operates medical marijuana dispensaries and related businesses, leveraging patented technology that utilizes liquid nitrogen to separate, collect, and protect high-value compounds from harvested plants. The firm owns a Trichome Separation unit, known as the CryoMass patented liquid nitrogen system, which is optimized for capturing fully intact cannabis and hemp trichomes along with terpenes. This system stabilizes and collects trichomes at harvest, preventing wasteful loss and functioning effectively within minutes after plants are cut or on fresh frozen and dried plant parts including trim. The company generates revenue by selling its proprietary Trichome Separation system to entities involved in the cultivation and processing of cannabis and hemp. By offering a solution that efficiently captures valuable compounds from various plant states, CryoMass Technologies targets customers seeking to maximize yield and quality in the medical marijuana sector. The business model relies on the unique capabilities of its liquid nitrogen technology to provide a superior alternative to traditional extraction methods, appealing to dispensaries and related businesses looking to enhance their operational efficiency and product integrity. Cryomass Technologies is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cryomass Technologies stock

Free Cash Flow Yield of Cryomass Technologies is -1.64 M % in 2023.

Free Cash Flow Yield of Cryomass Technologies changed from -2.18 M % to -1.64 M %, representing a -24.92% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Yield Cryomass Technologies since 2006 – with annual values, charts, and detailed analysis.

FCF Yield measures the free cash flow per share relative to the stock price. It indicates how much cash a company generates for each dollar invested.

To evaluate Free Cash Flow Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Yield's Cryomass Technologies with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Cryomass Technologies

All Key Metrics — Cryomass Technologies